Is CARE Ratings a Good Buy After Its Q1 FY27 Results?

The CARE Ratings share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. CARE Ratings is one of India's leading credit rating agencies, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.

Revenue for the quarter came in at Rs 126 crore, up 17.5% year on year, while profit after tax came in at Rs 33 crore, up 24.5% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the CARE Ratings share price from here.

This piece works through the quarter's financial highlights, the business factors behind the numbers, where the CARE Ratings share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.

Click Here – Get Free Investment Predictions

CARE Ratings Q1 FY27 Financial Highlights

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue	Rs 126 crore	Rs 108 crore	17.5%
EBITDA	Rs 49 crore	Rs 41 crore	19.3%
Operating Margin	44.3%	44.1%	NA
Profit Before Tax	Rs 45 crore	Rs 37 crore	20.1%
Net Profit / (Loss)	Rs 33 crore	Rs 26 crore	24.5%

CARE Ratings Q1 FY27 Performance Analysis

Check CARE Ratings Fundamentals on Univest Screener

Revenue growth of 17.5% for the quarter came from steady demand across the company's core business, keeping the topline trend intact for the credit rating services sector.

The bigger story is on profitability. PAT grew 24% to Rs 33 crore, comfortably ahead of revenue growth, which points to margin expansion or a favourable base effect. This is the kind of quarter that supports the premium the CARE Ratings share price already commands, though investors should check whether the growth is repeatable or was helped by one-off factors.

On a sequential basis, revenue moved down 13.6% sequentially from Rs 146 crore in the March 2026 quarter and net profit moved down 38.3% sequentially from Rs 53 crore in the prior quarter, giving a fuller picture of the trend behind the CARE Ratings share price than the year on year comparison alone.

Key Business Factors in Q1 FY27

Revenue Trend

CARE Ratings' revenue grew 17.5% year on year this quarter, taking the quarterly base to Rs 126 crore in a credit rating services business that remains sensitive to demand and pricing cycles that ultimately feed through to the CARE Ratings share price.

Margin Movement

EBITDA rose 19.3% to Rs 49 crore, and operating margin moved to 44.3% from 44.1% a year earlier, a sign that cost control or pricing held up during the quarter.

Balance Sheet Position

CARE Ratings carries a low debt-to-equity ratio of 0.03, giving it a conservative balance sheet heading into the rest of FY27.

Valuation Context

The stock trades at a PE of 28.8x, below the industry average of 35.7x, which is worth factoring into any read of whether the CARE Ratings share price is expensive or reasonably priced.

Dividend Details

No interim dividend was declared alongside CARE Ratings' Q1 FY27 results. The stock currently carries a trailing dividend yield of 1.28%, based on dividends paid over the last year. Investors tracking the CARE Ratings share price for income should watch the company's announcements around its next annual results for any dividend decision.

CARE Ratings Share Price Outlook for FY27

The Q1 FY27 print sets a reasonably high bar for the rest of the year. If CARE Ratings can sustain this pace of revenue and profit growth, the current valuation gets easier to justify. The main swing factor is whether this quarter's momentum reflects a durable trend or a favourable one-off, something the next two quarters should clarify.

For the CARE Ratings share price to hold its current premium through FY27, the company will likely need to keep posting growth at or near this quarter's pace, since any slowdown would put pressure on a stock priced for continued strength.

CARE Ratings Stock Performance

Download the Univest iOS App or Univest Android App to track CARE Ratings' live share price and get daily stock updates.

The CARE Ratings share price was trading around Rs 1,717 as results season played out in late August 2026, roughly 6.6% below its 52-week high of Rs 1,838 and well above its 52-week low of Rs 1,393.

The CARE Ratings share price has room to re-rate further if the growth shown this quarter continues, though much of the good news may already be reflected in the stock near current levels. On profitability ratios, the company reports a return on equity of 18.36% and a book value of around Rs 310 per share, both useful reference points when judging whether the current price is reasonable.

Key Risks

Sector and Demand Risk

As a credit rating services business, CARE Ratings' results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the CARE Ratings share price well before the next result.

Execution Risk

Sustaining this quarter's trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.

Conclusion

CARE Ratings' Q1 FY27 results were genuinely strong, with revenue at Rs 126 crore and PAT up 24% to Rs 33 crore. That said, at a PE of 28.8x, the CARE Ratings share price is not inexpensive, so this looks like a quality business trading at a full price rather than a bargain. Existing investors have little to worry about from this print, while new investors asking whether CARE Ratings is a good buy should weigh the strong quarter against the valuation before adding at current levels.

Frequently Asked Questions on CARE Ratings Q1 FY27 Results

What were CARE Ratings' Q1 FY27 results?

Ans. CARE Ratings reported Q1 FY27 revenue of Rs 126 crore, up 17.5% year on year, and PAT of Rs 33 crore, up 24.5% year on year.

Is CARE Ratings a good buy after its Q1 FY27 results?

Ans. CARE Ratings' core numbers improved this quarter, though at a PE of 28.8x the stock is not inexpensive, so this suits investors comfortable paying up for quality. Investors should form their own view based on their own risk appetite and time horizon.

What is the CARE Ratings share price today?

Ans. The CARE Ratings share price was trading around Rs 1,717 in late August 2026, about 6.6% below its 52-week high of Rs 1,838 and well above its 52-week low of Rs 1,393.

What is CARE Ratings' revenue and profit for Q1 FY27?

Ans. CARE Ratings reported revenue of Rs 126 crore and a net profit of Rs 33 crore for the quarter ended June 30, 2026.

Did CARE Ratings declare a dividend with its Q1 FY27 results?

Ans. No interim dividend was declared alongside CARE Ratings' Q1 FY27 results. Investors should track the company's next annual results for any dividend announcement.

What is CARE Ratings' PE ratio and is it expensive?

Ans. The CARE Ratings share price trades at a trailing PE of 28.8x, against an industry average of 35.7x. Investors should compare this with the company's growth rate before judging value.

What are the key risks for CARE Ratings investors right now?

Ans. As a credit rating services business, CARE Ratings' results remain tied to sector-specific demand, pricing and regulatory cycles that can shift from quarter to quarter and move the CARE Ratings share price well before the next result. Sustaining this quarter's trend into the rest of FY27 depends on management execution on costs, pricing and demand, none of which are guaranteed.

What is CARE Ratings' promoter shareholding?

Ans. Promoter shareholding data for CARE Ratings was not fully available for this quarter and should be checked on the company's official filings.